MTCH vs TCRX · P/E 13, rev $1.72B vs rev $2.0M
Match Group Inc (MTCH) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported MTCH revenue for 2026-06-30 was $1.72B. Net income was $337.4M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
MTCH currently screens at market cap $8.24B and trailing P/E 13.5. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the MTCH and TCRX stock pages for the full models.
Not investment advice.